×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Tenaya Therapeutics Financial Statements 2019-2025 | TNYA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Revenue
-
-
-
-
-
-
Cost Of Goods Sold
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Research And Development Expenses
$86.742
$98.038
$94.537
$54.393
$31.099
$23.148
SG&A Expenses
$29.206
$33.155
$31.084
$18.413
$7.813
$4.564
Other Operating Income Or Expenses
-
-
-
-
-
-
Operating Expenses
-
-
-
-
-
-
Operating Income
$-115.948
$-131.193
$-125.621
$-72.806
$-38.912
$-27.712
Total Non-Operating Income/Expense
$4.819
$7.109
$1.956
$0.085
$0.517
$1.481
Pre-Tax Income
$-111.129
$-124.084
$-123.665
$-72.721
$-38.395
$-26.231
Income Taxes
-
-
-
-
-
-
Income After Taxes
$-111.129
$-124.084
$-123.665
$-72.721
$-38.395
$-26.231
Other Income
-
-
-
-
-
-
Income From Continuous Operations
$-111.129
$-124.084
$-123.665
$-72.721
$-38.395
$-26.231
Income From Discontinued Operations
-
-
-
-
-
-
Net Income
$-111.129
$-124.084
$-123.665
$-72.721
$-38.395
$-26.231
EBITDA
$-107.664
$-122.191
$-119.461
$-69.714
$-36.429
$-25.723
EBIT
$-115.948
$-131.193
$-125.621
$-72.806
$-38.912
$-27.712
Basic Shares Outstanding
85
74
45
18
1
1
Shares Outstanding
85
74
45
18
1
1
Basic EPS
$-1.31
$-1.68
$-2.76
$-4.10
$-39.50
$-34.71
EPS - Earnings Per Share
$-1.31
$-1.68
$-2.76
$-4.10
$-39.50
$-34.71
www.jqwidgets.com